Poly(Vinylpyrollidone)- and Selenocysteine-Modified Bi₂Se₃ Nanoparticles Enhance Radiotherapy Efficacy in Tumors and Promote Radioprotection in Normal Tissues

Keyphrases

• Tumor 100%
• Radioprotection 100%
• Bismuth Telluride 100%
• Selenocysteine 100%
• Radiotherapy Efficacy 100%
• Bi2Se3 Nanoparticles 100%
• Radiation Effects 40%
• Radiosensitization 40%
• Nanoparticles 20%
• Whole-body 20%
• Radiation Therapy 20%
• High Biocompatibility 20%
• Marrow 20%
• White Blood Cells 20%
• Radioresistance 20%
• X-ray Irradiation 20%
• Tumor Tissue 20%
• Immune Function 20%
• Glutathione Peroxidase (GSH-Px) 20%
• Superoxide Dismutase 20%
• Healthy Tissue 20%
• Selenium 20%
• Attenuation Ability 20%
• X-ray Attenuation 20%
• Radiotherapeutics 20%
• Free Radical Generation 20%
• NIR Absorption 20%
• NIR Irradiation 20%
• Theranostics 20%
• Photothermal Effect 20%
• Absorptive Capacity 20%
• In Vitro Toxicity 20%
• Blood Circulation System 20%
• 808 Nm NIR 20%

Immunology and Microbiology

• X Ray 100%
• Glutathione 50%
• Cytokine 50%
• Leukocyte 50%
• Secretion (Process) 50%
• Radiosensitization 50%
• Radioresistance 50%
• Peroxidase 50%
• Absorption 50%
• Superoxide Dismutase 50%
• In Vitro 50%

Material Science

• Nanoparticle 100%
• Tumor 50%
• Biocompatibility 50%
• Peroxidase 50%
• Superoxide Dismutase 50%
• Glutathione 50%